Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: Analysis of prognostic factors

Cancer

Volumn 77, Issue 12, 1996, Pages 2476-2488

  Stasi, Roberto ^a,c   Venditti, Adriano ^a   Del Poeta, Giovanni ^b   Aronica, Germano ^a   Dentamaro, Teresa ^a   Cecconi, Manrico ^b   Stipa, Elisa ^b   Scimó, Maria Teresa ^b   Masi, Mario ^b   Amadori, Sergio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b S EUGENIO HOSPITAL   (Italy)

^c NONE   (Italy)

Author keywords

acute myeloid leukemia; CD14; chemotherapy; elderly patients; immunophenotype; karyotype; prognosis

Indexed keywords

CD14 ANTIGEN; CD7 ANTIGEN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL PROTOCOL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ANTIGENS, CD14; ANTIGENS, CD7; BONE MARROW; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; TREATMENT OUTCOME;

EID: 9344271570     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960615)77:12<2476::AID-CNCR10>3.0.CO;2-P     Document Type: Article

References (40)

1. Ries LAG, Hankey BF, Miller BA. Cancer statistics review 1973-1988. Bethesda (MD): National Cancer Institute; 1991. NIH Pub. No. 91-2789.
2. Gale RP, Foon KA. Therapy of acute myelogenous leukemia. Semin Hematol 1987;24:40-54.
3. Foon KA, Zighelboim J, Yale C, Gale RP. Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemia. Blood 1981;58:467-70.
4. Liu Yin JA, Johnson PRE, Davies JM, Flanagan NG, Gorst DW, Lewis MJ. Mitozantrone and cytosine arabinoside as first-line therapy in elderly patients with acute myeloid leukaemia. Br J Haematol 1991;79:415-20.
5. Rees JKH, Swirsky D, Gray RG, Hayhoe FGJ. Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial. Lancet 1986;2:1236-41.
6. Harousseau H, Castaigne S, Milpied N, Marty M, Degos L. Treatment of acute nonlymphoblastic leukemia in elderly patients. Lancet 1984;1:288-91.
7. Walters DS, Kantarjian HM, Keating MJ, Estey EH, McCredie KB, Freireich EJ. Intensive treatment of acute leukemia in adults 70 years of age and older. Cancer 1987;60:149-55.
8. Sebban C, Archimbaud FR, Coiffier B, Guyotat D, Treille-Ritouet D, Maupas J, et al. Treatment of acute myeloid leukemia in elderly patients. Cancer 1988;61:227-31.
9. Orlandi E, Lazzarino M, Morra E, Castagnola C, Alessandrino EP, Bernasconi P, et al. Impact of advanced age on the management of acute nonlymphocytic leukemia: a study of 103 patients. Acta Haematol 1990;84:144-8.
10. Tilly H, Castaigne S, Bordessoule D, Casassus P, Le Prise PY, Tertian G, et al. Low-dose cytarabine versus intensive chemotherapy in the treatment of nonlymphocytic leukemia in the elderly. J Clin Oncol 1990;8:272-9.
11. Tucker J, Thomas AE, Gregory WM, Ganesan TS, Malik STA, Amess JAL, et al. Acute myeloid leukemia in elderly adults. Hematol Oncol 1990;8:13-21.
12. Whitely R, Hannah P, Holmes F. Survival in acute leukemia in elderly patients. No improvement in the 1980's. J Am Geriatr Soc 1990;38:527-30.
13. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, et al. Intensive remission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 1994;331:896-903.
14. Keating MJ, McCredie KB, Benjamin RS, Bodey GP, Spitzer G, Hersh E, et al. Factors related to length of complete remission in adult acute leukemia. Cancer 1981;45:2017-24.
15. Bernard P, Lacombe F, Reiffers J, David B, Marit DG, Bourdeau MJ, et al. Relationship between patients' age, bone marrow karyotype, and outcome of induction therapy in acute myelogenous leukemia. Am J Hematol 1985;18:153-60.
16. Swirsky DM, De Bastos M, Parish SE, Rees JKH, Hayhoe FGJ. Features affecting outcome during remission induction of acute myeloid leukaemia in 619 adult patients. Br J Haematol 1987;64:435-41.
17. Wahlin A, Hörnsten P, Jonsson H. Remission rate and survival in acute myeloid leukemia: impact of selection and chemotherapy. Eur J Haematol 1991;46:240-5.
18. Baudard M, Marie JP, Cadiou M, Viguié F, Zittoun R. Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients. Br J Haematol 1994;86:82-91.
19. Johnson PRE, Hunt LP, Liu Yin JA. Prognostic factors in elderly patients with acute myeloid leukaemia: development of a model to predict survival. Br J Haematol 1994;85:300-6.
20. Preisler HD. Treatment failure in AML. Blood Cells 1982; 8:585-94.
21. Stasi R, Tribalto M, Venditti A, Del Poeta G, Aronica G, Zaccari G, et al. Simultaneous occurrence of monoclonal gammopathy and acute secondary leukemia with overexpression of P-glycoprotein. Tumori 1992;78:403-6.
22. Stasi R, Del Poeta G, Masi M, Tribalto M, Venditti A, Papa G, et al. Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemia. Cancer Genet Cytogenet 1993;67:28-35.
23. Stasi R, Del Poeta G, Venditti A, Masi M, Stipa E, Dentamaro T, et al. Analysis of treatment failure in patients with minimally differentiated acute myeloid leukaemia (AML-M0). Blood 1994;83:1619-25.
24. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton AG, Gralnick HR, et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985;103:620-5.
25. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton AG, Gralnick HR, et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0). Br J Haematol 1991;78:325-9.
26. Catovsky D, Matutes E. The classification of acute leukemia. Leukemia 1992;6(Suppl 2):1-6.
27. Mitelman F, editor. International System for Human Cytogenetic Nomenclature 1991. Basel: Karger, 1991.
28. Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 1994;86:829-36.
29. Smith DG, Clemens J, Crede W, Harvey M, Gracely E. Impact of multiple comparisons in randomized clinical trials. Am J Med 1987;83:545-50.
30. Resegotti L. Treatment of acute non lymphoid leukemia (ANLL) in elderly patients. The GIMEMA experience. Leukemia 1992;6(Suppl 2):72-5.
31. Arlin Z, Case DC Jr., Moore J, Wiernik P, Feldman E, Saletan S, et al. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Leukemia 1990;4:177-83.
32. Loewenberg B, Zittoun R, Kerkhofs H, Jehn U, Abels J, Debusscher L, et al. On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase-III study of the European Organization for Research and Treatment of Cancer Leukemia Group. J Clin Oncol 1989;7:1268-74.
33. Ferrara F, Mele G, Mettivier V, Mirto S, Cimino R. Idarubicin as treatment for acute myelogenous leukemia in the elderly. Leuk Lymphoma 1992;7 (Suppl 2):4-7.
34. Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G, Bruno A, et al. Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Leukemia 1994;8:388-94.
35. Mitelman F, Brandt L, Nilsson PG. Relation among occupational exposure to potential mutagenic/carcinogenic agents, clinical findings, and bone marrow chromosomes in acute nonlymphocytic leukemia. Blood 1978;52:1229-37.
36. Fialkow PJ, Singer JW, Adamson JW, Vaidya K, Dow LW, Ochs J, et al. Acute nonlymphocytic leukemia: heterogeneity of stem cell origin. Blood 1981;57:1068-73.
37. Chabannon C, Wood P, Torok-Storb B. Expression of CD7 on normal human myeloid progenitors. J Immunol 1992; 149:2110-3.
38. Zutter MM, Martin PJ, Hanke D, Kidd PG. CD7+ acute nonlymphocytic leukemia: evidence for an early multipotential progenitor. Leuk Res 1990;14:23-6.
39. Raza A, Preisler HD, Day R, Yasin Z, White M, Lykins J, et al. Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics: a Leukemia Intergroup study. Blood 1990;76:2191-7.
40. Fialkow PJ, Singer JW, Raskind WH, Adamson JW, Jacobson RJ, Bernstein ID, et al. Clonal development, stem cell differentiation, and clinical remission in acute nonlymphocytic leukemia. N Engl J Med 1987;317:468-73.